- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Revenue of Johnson & Johnson 2006-2018 by region
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Revenue of Johnson & Johnson 2006-2018 by region
Johnson & Johnson's revenue from 2006 to 2018, by region (in million U.S. dollars)

Johnson & Johnson’s global positioning
Johnson & Johnson was among the top pharmaceutical companies globally in recent years. Based on prescription sales and research and development spending, Johnson & Johnson was ranked as the fifth in prescription sales and second in research and development. In terms of the research and development pipeline, Johnson & Johnson ranked among the top three pharmaceutical companies worldwide as of 2019.
Research and development at Johnson & Johnson
Johnson & Johnson’s expenditures on research and development, like their revenue, has been increasing in recent years. However, when viewed as percentage of revenue, research and development spending has only slightly increased recently. Compared to other companies, Johnson & Johnson was among the top three based on research and development spending in 2017. However, by 2024, they are expected to be surpassed by others in research and development spending.
Johnson & Johnson's revenue from 2006 to 2018, by region (in million U.S. dollars)
Western Hemisphere (excluding U.S.) | Asia-Pacific, Africa | Europe | United States | |
---|---|---|---|---|
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
Western Hemisphere (excluding U.S.) | Asia-Pacific, Africa | Europe | United States | |
---|---|---|---|---|
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
- | - | - | - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
Johnson & Johnson’s global positioning
Johnson & Johnson was among the top pharmaceutical companies globally in recent years. Based on prescription sales and research and development spending, Johnson & Johnson was ranked as the fifth in prescription sales and second in research and development. In terms of the research and development pipeline, Johnson & Johnson ranked among the top three pharmaceutical companies worldwide as of 2019.
Research and development at Johnson & Johnson
Johnson & Johnson’s expenditures on research and development, like their revenue, has been increasing in recent years. However, when viewed as percentage of revenue, research and development spending has only slightly increased recently. Compared to other companies, Johnson & Johnson was among the top three based on research and development spending in 2017. However, by 2024, they are expected to be surpassed by others in research and development spending.
- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- Worldwide
- Survey time period
- 2006 to 2018
- Supplementary notes
- Figures prior to 2016 were taken from previous annual reports.
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- Worldwide
- Survey time period
- 2006 to 2018
- Supplementary notes
- Figures prior to 2016 were taken from previous annual reports.
Other statistics on the topic
Johnson & Johnson
Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018

Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019

Pharmaceutical Products & Market
Revenue of Johnson & Johnson worldwide 2011-2018, by segment

Pharmaceutical Products & Market
Johnson & Johnson's number of employees 2004-2018
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate solution including all features.
Prices do not include sales tax.






All Information
in one Presentation
- 48 page/s
- English
- pptx
- Detailed references
Everything On "Johnson & Johnson" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
- Global positioning
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- 2019 ranking of the global top 10 biotech and pharmaceutical companies based on employee number (in 1,000)2019 list of global top 10 biotech and pharmaceutical companies by employees
- Top 10 pharmaceutical companies worldwide by size of R&D pipeline in 2019*Top pharma companies worldwide 2019, by size of R&D pipeline
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*Top pharma companies worldwide by number of originated drugs 2019
- Revenue and income
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2018
- Revenue of Johnson & Johnson worldwide from 2011 to 2018, by segment (in million U.S. dollars)Revenue of Johnson & Johnson worldwide 2011-2018, by segment
- Johnson & Johnson's revenue from 2006 to 2018, by region (in million U.S. dollars)Revenue of Johnson & Johnson 2006-2018 by region
- Johnson & Johnson's net income from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's net income 2005-2018
- Segments
- Revenue of Johnson & Johnson's top pharmaceutical products from 2014 to 2018 (in million U.S. dollars)Revenue of Johnson & Johnson's pharmaceutical products 2014-2018
- Revenue of Johnson & Johnson's medical devices and diagnostics segment from 2016 to 2018, by franchise (in million U.S. dollars)Revenue of Johnson & Johnson's medical devices and diagnostics by franchise 2016-2018
- Revenue of Johnson & Johnson's consumer healthcare segment from 2014 to 2018, by franchise (in million U.S. dollars)Revenue of Johnson & Johnson's consumer healthcare segment by franchise 2014-2018
- Miscellaneous
- Johnson & Johnson's expenditure on research and development from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's expenditure on research and development 2005-2018
- Johnson & Johnson's research and development expenditure as a percent of revenue from 2005 to 2018Johnson & Johnson's R&D expenditure as a percent of revenue 2005-2018
- Johnson & Johnson's number of employees from 2004 to 2018 (in 1,000)Johnson & Johnson's number of employees 2004-2018
- Brand value of Johnson & Johnson's cosmetic brands worldwide from 2017 to 2019 (in billion U.S. dollars)Brand value of Johnson & Johnson's cosmetic brands worldwide 2017-2019
- Forecasts
- Revenue of Johnson & Johnson's pharmaceuticals segment worldwide from 2012 to 2024, by product category* (in billion U.S. dollars)Revenue of Johnson & Johnson's pharmaceuticals segment worldwide 2012-2024
- Johnson & Johnson's market share of the over-the-counter and nutritionals market worldwide from 2013 to 2021*Johnson & Johnson's market share of the global OTC and nutritionals market
- Forecast of EBITDA of Johnson & Johnson for 2019 to 2021 (in million U.S. dollars)Forecast of EBITDA of Johnson & Johnson 2019-2021
- Revenue of Johnson & Johnson's consumer health segment worldwide 2012-2024
- Johnson & Johnson employees involved in R&D in 2017 and 2018
- Number of health workers educated by Johnson & Johnson globally from 2016 to 2018
- Total revenue of Johnson & Johnson worldwide 2012-2024
- Johnson & Johnson: ad spend in Canada 2012-2013
- Revenue of Johnson & Johnson worldwide 2018-2024, by segment
- Breakdown of Johnson & Johnson's revenue worldwide 2013-2021, by sub-category
- Johnson & Johnson's share of the skin care products market worldwide 2013-2021
- Johnson & Johnson's bought energy consumption 2010-2018
- Johnson & Johnson's consumed on-site energy generation by source 2018
- Usage frequency of Reach dental floss / flossers / picks in the U.S. 2019
- Chile: J&J's body care market share 2015-2016
- Johnson & Johnson: advertising spending worldwide 2011-2014
- Johnson & Johnson - ad spend in the U.S. 2014, by medium
- Johnson & Johnson magazine ad spend in Canada 2011-2014
- Johnson & Johnson: ad spend in the U.S. 2009-2014
- World pharmaceutical market CAGR forecast by region group 2019-2023
- Dr. Reddy's Laboratories Limited number of shares traded FY 2018
- 3D printing polymers: global market size 2016/2023
- Disruptions to global oil supplies
- Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top 10 biotech and pharmaceutical companies based on market cap 2019
- 2019 list of global top 10 biotech and pharmaceutical companies by employees
- Top pharma companies worldwide 2019, by size of R&D pipeline
- Top pharma companies worldwide by number of originated drugs 2019
- Revenue of Johnson & Johnson's consumer health segment worldwide 2012-2024
- Johnson & Johnson employees involved in R&D in 2017 and 2018
- Number of health workers educated by Johnson & Johnson globally from 2016 to 2018
- Total revenue of Johnson & Johnson worldwide 2012-2024
- Johnson & Johnson: ad spend in Canada 2012-2013
- Revenue of Johnson & Johnson worldwide 2018-2024, by segment
- Breakdown of Johnson & Johnson's revenue worldwide 2013-2021, by sub-category
- Johnson & Johnson's share of the skin care products market worldwide 2013-2021
- Johnson & Johnson's bought energy consumption 2010-2018
- Johnson & Johnson's consumed on-site energy generation by source 2018
- Usage frequency of Reach dental floss / flossers / picks in the U.S. 2019
- Chile: J&J's body care market share 2015-2016
- Johnson & Johnson: advertising spending worldwide 2011-2014
- Johnson & Johnson - ad spend in the U.S. 2014, by medium
- Johnson & Johnson magazine ad spend in Canada 2011-2014
- Johnson & Johnson: ad spend in the U.S. 2009-2014
- World pharmaceutical market CAGR forecast by region group 2019-2023
- Dr. Reddy's Laboratories Limited number of shares traded FY 2018
- 3D printing polymers: global market size 2016/2023
- Disruptions to global oil supplies
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
...and make my research life easier.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.